Shanghai Fosun Pharmaceutical Group Co Ltd
OTC:SFOSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Shanghai Fosun Pharmaceutical Group Co Ltd (SFOSF) under the Base Case is USD per share.
Compared with the current market price of 1.875 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Shanghai Fosun Pharmaceutical Group Does
Shanghai Fosun Pharmaceutical Group is a Chinese healthcare company that makes and sells prescription drugs, specialty medicines, and some medical products. It develops and manufactures treatments for areas such as cancer, infection, central nervous system disorders, and blood-related diseases, and it also works with outside partners to bring in licensed medicines for the China market. In simple terms, it sits between drug developers and hospitals, helping turn drug research into products that doctors can use.
- Headquarters
- China CN
- Employees
- 40 603
- IPO date
- Aug 7, 1998
Continue SFOSF Research
Decided on Shanghai Fosun Pharmaceutical Group? Get an email when SFOSF reaches the price you’d buy at. Free with an account.
Other Shanghai Fosun Pharmaceutical Group listings
What is the Intrinsic Value of one SFOSF stock?
The intrinsic value for
Shanghai Fosun Pharmaceutical Group Co Ltd (SFOSF) under the Base Case is USD.
Is SFOSF stock undervalued or overvalued?
Compared with the current market price of 1.875 USD, the stock appears .